Related Experiment Video
Updated: Apr 30, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Blocking the janus-activated kinase pathway reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity by
Introduction:
Our objective was to examine the role of the janus-activated kinase (JAK) pathway in the modulation of tumor necrosis factor-α (TNF)-induced-IL-18 bioactivity by reduction of caspase-1 function.
Methods:
Caspase-1 expression in rheumatoid arthritis (RA) synovial fibroblasts treated with TNF was assessed by qRT-PCR and Western blot. Interleukin (IL)-18 was assessed by enzyme-linked immunosorbent assay (ELISA) in cell lysates and conditioned media and detected by immunofluorescence (IF) staining in RA synovial fibroblasts. The critical pathways for TNF-induced caspase-1 expression were determined by using chemical inhibitors of signaling followed by TNF stimulation. IL-18 bioactivity was assessed using human myelomonocytic KG-1 cells.
Results:
TNF induced RA synovial fibroblast caspase-1 expression at the protein level in a time-dependant manner (P < 0.05). Blocking the JAK pathway reduced TNF-induced-caspase-1 expression at the transcriptional and protein levels by approximately 60% and 40%, respectively (P < 0.05). Blocking the JAK pathway reduced TNF-induced-caspase-1 expression at the transcriptional, protein, and activity levels by approximately 60%, 40%, and 53%, respectively (P < 0.05). We then confirmed by IF that TNF-induced IL-18 and investigated roles of the ERK1/2 and JAK pathways. Blocking the JAK pathway, TNF induced intracytoplasmic granular IL-18 expression suggesting a defect of caspase-1. Finally, blocking the JAK pathway, we observed a reduction of IL-18 bioactivity by 52% in RA synovial fibroblasts (P < 0.05).
Conclusions:
These results provide a new way to regulate TNF-induced-IL-18 bioactivity by blocking capase-1. These data present a novel role for JAK inhibition in RA patients and emphasize JAK inhibition use as a new therapeutic option in RA management.
Insights
Blocking the janus-activated kinase (JAK) pathway reduces tumor necrosis factor-α (TNF)-induced interleukin-18 (IL-18) bioactivity by inhibiting caspase-1. This suggests JAK inhibition is a potential therapeutic strategy for rheumatoid arthritis (RA).
Area of Science:
- Immunology and Inflammation Research
- Molecular Biology and Signaling Pathways
Background:
- Tumor necrosis factor-α (TNF) plays a key role in the inflammatory processes of rheumatoid arthritis (RA).
- Interleukin-18 (IL-18) is a pro-inflammatory cytokine implicated in RA pathogenesis.
- The janus-activated kinase (JAK) pathway is a critical signaling cascade involved in immune responses.
Purpose of the Study:
- To investigate the role of the JAK pathway in modulating TNF-induced IL-18 bioactivity.
- To examine the impact of reducing caspase-1 function on TNF-induced IL-18 bioactivity.
- To explore the potential of JAK inhibition as a therapeutic approach for RA.
Main Methods:
- Caspase-1 expression in RA synovial fibroblasts stimulated with TNF was analyzed using qRT-PCR and Western blot.
- IL-18 levels and bioactivity were assessed via ELISA, immunofluorescence (IF), and functional assays with KG-1 cells.
- The involvement of JAK and ERK1/2 pathways was determined using chemical signaling inhibitors.
Main Results:
- TNF significantly increased caspase-1 expression in RA synovial fibroblasts at the protein level.
- Inhibition of the JAK pathway markedly reduced TNF-induced caspase-1 expression (transcriptional and protein levels) and IL-18 bioactivity.
- Blocking the JAK pathway led to intracytoplasmic granular IL-18 expression, indicating impaired caspase-1 processing.
Conclusions:
- The JAK pathway is crucial for regulating TNF-induced IL-18 bioactivity in RA synovial fibroblasts.
- Inhibition of caspase-1, modulated by JAK signaling, offers a novel mechanism to control IL-18 bioactivity.
- JAK inhibition presents a promising therapeutic avenue for managing rheumatoid arthritis.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
08:41Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
Published on: April 6, 2022
Related Concept Videos
The JAK-STAT Signaling Pathway
The Extrinsic Apoptotic Pathway
Caspases
The Intrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...